{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:31:23Z","timestamp":1760236283365,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K08197"],"award-info":[{"award-number":["20K08197"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Glycogen storage disease type Ia (GSDIa) is an autosomal recessive disorder caused by glucose-6-phosphatase (G6PC) deficiency. GSDIa causes not only life-threatening hypoglycemia in infancy, but also hepatocellular adenoma as a long-term complication. Hepatocellular adenoma may undergo malignant transformation to hepatocellular carcinoma. New treatment approaches are keenly anticipated for the prevention of hepatic tumors. Gene replacement therapy (GRT) is a promising approach, although early treatment in infancy is essential for its safety and efficiency. Thus, GRT requires screening systems for early disease detection. In this study, we developed a screening system for GSDIa using dried blood spots (DBS) on filter paper, which can detect the most common causative mutation in the East-Asian population, c.648G&gt;T in the G6PC gene. Our system consisted of nested PCR analysis with modified competitive oligonucleotide priming (mCOP)-PCR in the second round and melting curve analysis of the amplified products. Here, we tested 54 DBS samples from 50 c.648G (wild type) controls and four c.648T (mutant) patients. This system, using DBS samples, specifically amplified and clearly detected wild-type and mutant alleles from controls and patients, respectively. In conclusion, our system will be applicable to newborn screening for GSDIa in the real world.<\/jats:p>","DOI":"10.3390\/ijns7040079","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T21:32:07Z","timestamp":1637184727000},"page":"79","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G&gt;T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-3448","authenticated-orcid":false,"given":"Emma Tabe Eko","family":"Niba","sequence":"first","affiliation":[{"name":"Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8066-9211","authenticated-orcid":false,"given":"Yogik Onky Silvana","family":"Wijaya","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-4142","authenticated-orcid":false,"given":"Hiroyuki","family":"Awano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-7185","authenticated-orcid":false,"given":"Yasuhiro","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6778-4511","authenticated-orcid":false,"given":"Hisahide","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan"},{"name":"Faculty of Rehabilitation, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Kobe 651-2180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0021-9258(18)38504-1","article-title":"Glucose-6-Phosphatase of the Liver in Glycogen Storage Disease","volume":"199","author":"Cori","year":"1952","journal-title":"J. Biol. Chem."},{"key":"ref_2","first-page":"30","article-title":"Molecular Diagnosis of Glycogen Storage Disease Type I: A Review","volume":"18","author":"Beyzaei","year":"2019","journal-title":"EXCLI J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajmg.a.30232","article-title":"Mutation Frequencies for Glycogen Storage Disease Ia in the Ashkenazi Jewish Population","volume":"129A","author":"Ekstein","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI117192","article-title":"Identification of Mutations in the Gene for Glucose-6-Phosphatase, the Enzyme Deficient in Glycogen Storage Disease Type 1a","volume":"93","author":"Lei","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_5","unstructured":"(2020, October 09). Human Gene Mutation Database. Available online: http:\/\/www.Hgmd.Cf.Ac.Uk\/Ac\/Index.Php."},{"key":"ref_6","first-page":"766","article-title":"Genetic Basis of Glycogen Storage Disease Type 1a: Prevalent Mutations at the Glucose-6-Phosphatase Locus","volume":"57","author":"Lei","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.0.CO;2-Y","article-title":"Glycogen Storage Disease Type Ia: Molecular Diagnosis of 51 Japanese Patients and Characterization of Splicing Mutations by Analysis of Ectopically Transcribed MRNA from Lymphoblastoid Cells","volume":"91","author":"Akanuma","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13023-020-1321-0","article-title":"Predominance of the c.648G>T G6PC Gene Mutation and Late Complications in Korean Patients with Glycogen Storage Disease Type Ia","volume":"15","author":"Kim","year":"2020","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_9","first-page":"549","article-title":"Exon Redefinition by a Point Mutation within Exon 5 of the Glucose-6-Phosphatase Gene Is the Major Cause of Glycogen Storage Disease Type 1a in Japan","volume":"57","author":"Kajihara","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1399-0004.1998.tb02674.x","article-title":"Glucose-6-Phosphatase Gene (727G\u2192T) Splicing Mutation Is Prevalent in Hong Kong Chinese Patients with Glycogen Storage Disease Type La","volume":"53","author":"Lam","year":"2008","journal-title":"Clin. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1566524013364112","article-title":"The Molecular Basis of Type 1 Glycogen Storage Diseases","volume":"1","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and Management of Glycogen Storage Disease Type I: A Practice Guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000351022","article-title":"Impaired Bone Metabolism in Glycogen Storage Disease Type 1 Is Associated with Poor Metabolic Control in Type 1a and with Granulocyte Colony-Stimulating Factor Therapy in Type 1b","volume":"81","author":"Melis","year":"2014","journal-title":"Horm. Res. Paediatr."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Romano, A., Russo, D., Contaldo, M., Lauritano, D., della Vella, F., Serpico, R., Lucchese, A., and Stasio, D.D. (2020). Oral Manifestations in Patients with Glycogen Storage Disease: A Systematic Review of the Literature. Appl. Sci., 10.","DOI":"10.3390\/app10196720"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s005350170157","article-title":"Hepatocellular Adenoma in Type Ia Glycogen Storage Disease","volume":"36","author":"Kudo","year":"2001","journal-title":"J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cld.2015.01.010","article-title":"Hepatocellular Carcinoma in Children","volume":"19","author":"Kelly","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fped.2020.00591","article-title":"Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients","volume":"8","author":"Aoun","year":"2020","journal-title":"Front. Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.livres.2017.12.001","article-title":"Recent Development and Gene Therapy for Glycogen Storage Disease Type Ia","volume":"1","author":"Chou","year":"2017","journal-title":"Liver Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/BF02679996","article-title":"Adenovirus-Mediated Gene Therapy in a Mouse Model of Glycogen Storage Disease Type 1a","volume":"161","author":"Chou","year":"2002","journal-title":"Eur. J. Pediatrics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2017.01.003","article-title":"Glycogen Storage Disease Type Ia Mice with Less than 2% of Normal Hepatic Glucose-6-Phosphatase-\u03b1 Activity Restored Are at Risk of Developing Hepatic Tumors","volume":"120","author":"Kim","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ymthe.2018.01.006","article-title":"G6PC MRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a","volume":"26","author":"Roseman","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mt.2015.99","article-title":"Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates","volume":"23","author":"Hinderer","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/1475-2875-13-393","article-title":"A Nested Real-Time PCR Assay for the Quantification of Plasmodium Falciparum DNA Extracted from Dried Blood Spots","volume":"13","author":"Tran","year":"2014","journal-title":"Malar. J."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wijaya, Y.O.S., Purevsuren, J., Harahap, N.I.F., Niba, E.T.E., Bouike, Y., Nurputra, D.K., Rochmah, M.A., Thursina, C., Hapsara, S., and Yamaguchi, S. (2020). Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6020043"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene Abeparvovec: First Global Approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/mt.2013.266","article-title":"AAV9-Mediated Expression of a Non-Self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-Presenting Cell Transduction","volume":"22","author":"Samaranch","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Monahan, P.E., N\u00e9grier, C., Tarantino, M., Valentino, L.A., and Mingozzi, F. (2021). Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia. JCM, 10.","DOI":"10.3390\/jcm10112471"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2016.06.006","article-title":"Neonatal Tolerance Induction Enables Accurate Evaluation of Gene Therapy for MPS I in a Canine Model","volume":"119","author":"Hinderer","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10238-019-00557-8","article-title":"Adeno-Associated Virus as a Gene Therapy Vector: Strategies to Neutralize the Neutralizing Antibodies","volume":"19","author":"Lotfinia","year":"2019","journal-title":"Clin. Exp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/gt.2011.90","article-title":"Neutralizing Antibodies against Adeno-Associated Virus Examined Prospectively in Pediatric Patients with Hemophilia","volume":"19","author":"Li","year":"2012","journal-title":"Gene Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/jmv.23818","article-title":"The Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Capsids Is Reduced in Young Japanese Individuals: Prevalence of Antibodies Against AAV","volume":"86","author":"Mimuro","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1038\/s41467-021-23318-2","article-title":"MRNA Therapy Restores Euglycemia and Prevents Liver Tumors in Murine Model of Glycogen Storage Disease","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.braindev.2017.04.015","article-title":"Genetic Screening of Spinal Muscular Atrophy Using a Real-Time Modified COP-PCR Technique with Dried Blood-Spot DNA","volume":"39","author":"Harahap","year":"2017","journal-title":"Brain Dev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Shinohara, M., Niba, E.T.E., Wijaya, Y.O.S., Takayama, I., Mitsuishi, C., Kumasaka, S., Kondo, Y., Takatera, A., Hokuto, I., and Morioka, I. (2019). A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5040041"},{"key":"ref_35","first-page":"E44","article-title":"Spinal Muscular Atrophy: New Screening System with Real-Time MCOP-PCR and PCR-RFLP for SMN1 Deletion","volume":"65","author":"Niba","year":"2019","journal-title":"Kobe J. Med. Sci."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/7\/4\/79\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:31:04Z","timestamp":1760167864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/7\/4\/79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijns7040079"],"URL":"https:\/\/doi.org\/10.3390\/ijns7040079","relation":{},"ISSN":["2409-515X"],"issn-type":[{"type":"electronic","value":"2409-515X"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}